Monitoring of the medicines Adalimumab, infliximab and rituximab; tests for concentration and antibodies in serum to Helse Bergen HF
Tender information
TED EUVADSØ, Norway
- Type
- 29
- Procedure
- open
- Ref. number
- 70866-2024
- Estimated value
- 1,100,000 NOK
- CPV
- 33696500
Framework agreement for tests for measuring concentration and antibodies directed at the medicines Adalimumab, Infliximab and Rituximab in human serum.